Global Exogenous Circular RNA Synthesis Service Market Growth (Status and Outlook) 2026-2032
The global Exogenous Circular RNA Synthesis Service market size is predicted to grow from US$ 42.06 million in 2025 to US$ 218 million in 2032; it is expected to grow at a CAGR of 26.2% from 2026 to 2032.
Exogenous circular RNA synthesis services refer to specialized technical services that produce artificial circular RNA outside living cells based on customer-provided or jointly optimized sequences. The workflow typically includes DNA template construction, in vitro transcription, precursor RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. The delivered RNA has already formed a covalently closed circular structure before being introduced into cells, tissues, or living organisms. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circRNA samples, preclinical drug substance, formulated samples, process-development packages, and GMP-compliant clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials. Downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutes, and hospital research centers. Pricing is generally determined by sequence length, delivery scale, circularization method, purity grade, analytical requirements, formulation needs, and quality-system requirements. Research-grade projects are usually priced by sequence and quantity, while clinical and industrial projects are priced through process-development and batch-manufacturing contracts. The industry's overall gross margin in 2025 is estimated at approximately 40%?60%.
The exogenous circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although customer demand is expanding from basic circRNA sample preparation to sequence optimization, circularization screening, impurity removal, analytical method development, and delivery formulation. Early suppliers mainly delivered microgram- to milligram-scale research samples, while several integrated service providers have developed larger-scale production, LNP formulation, and clinical-grade quality systems. Global supply is concentrated mainly in China and the United States. Chinese providers have developed broad capabilities in circularization processes, research services, and integrated CRDMO support, while U.S.-based providers generally benefit from international customer coverage, standardized service models, and established nucleic acid development infrastructure. The market remains characterized by a limited supplier base, highly customized projects, and revenues concentrated in the development stage.
Future competition will shift from basic circularization capability toward high purity, scarless products, long-sequence compatibility, low immunogenicity, and reproducible scale-up. Conventional PIE methods have a relatively established application base but may face challenges involving junction scars, sequence restrictions, and by-product control. Modified scarless PIE and ligase-based approaches offer greater sequence flexibility but impose additional requirements on terminal structure, splint design, enzyme cost, and downstream purification. As customer programs enter clinical development, residual linear RNA, double-stranded RNA, truncated transcripts, free intron fragments, and residual DNA will become increasingly important quality attributes. Suppliers with proprietary analytical methods and biological potency testing capabilities will gain a stronger competitive position.
Market growth is being driven by expanding development activity in circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo cell therapies, and gene-editing research. Compared with building internal in vitro transcription and circularization platforms, outsourcing gives developers access to validated templates, circularization elements, purification processes, and analytical systems, reducing development risk and shortening timelines to animal studies and regulatory submissions. As programs move from discovery to preclinical and clinical stages, additional testing for circularization efficiency, purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency expands the service scope and contract value. Providers offering integrated template production, circRNA drug substance, LNP formulation, and quality studies will be better positioned to secure long-term projects.
The main barriers are the lack of harmonized quality and regulatory standards and differences in how suppliers measure circularization efficiency, purity, integrity, and expression activity. A high apparent circularization rate does not necessarily indicate high functional purity, because mis-ligated products, uncircularized precursors, double-stranded RNA, and truncated transcripts may affect expression and immune responses. Long-sequence circularization efficiency, purification recovery, and batch consistency remain technical challenges. Clinical-grade production also involves significant costs related to high-grade raw materials, quality validation, facility maintenance, and regulatory documentation. Because the number of clinical-stage exogenous circRNA programs remains limited, GMP capacity utilization and order continuity also constrain the stability of supplier profitability.
LPI (LP Information)' newest research report, the ?Exogenous Circular RNA Synthesis Service Industry Forecast? looks at past sales and reviews total world Exogenous Circular RNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Exogenous Circular RNA Synthesis Service sales for 2026 through 2032. With Exogenous Circular RNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exogenous Circular RNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global Exogenous Circular RNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exogenous Circular RNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Exogenous Circular RNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exogenous Circular RNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exogenous Circular RNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Exogenous Circular RNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exogenous circular RNA synthesis services refer to specialized technical services that produce artificial circular RNA outside living cells based on customer-provided or jointly optimized sequences. The workflow typically includes DNA template construction, in vitro transcription, precursor RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. The delivered RNA has already formed a covalently closed circular structure before being introduced into cells, tissues, or living organisms. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circRNA samples, preclinical drug substance, formulated samples, process-development packages, and GMP-compliant clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials. Downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutes, and hospital research centers. Pricing is generally determined by sequence length, delivery scale, circularization method, purity grade, analytical requirements, formulation needs, and quality-system requirements. Research-grade projects are usually priced by sequence and quantity, while clinical and industrial projects are priced through process-development and batch-manufacturing contracts. The industry's overall gross margin in 2025 is estimated at approximately 40%?60%.
The exogenous circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although customer demand is expanding from basic circRNA sample preparation to sequence optimization, circularization screening, impurity removal, analytical method development, and delivery formulation. Early suppliers mainly delivered microgram- to milligram-scale research samples, while several integrated service providers have developed larger-scale production, LNP formulation, and clinical-grade quality systems. Global supply is concentrated mainly in China and the United States. Chinese providers have developed broad capabilities in circularization processes, research services, and integrated CRDMO support, while U.S.-based providers generally benefit from international customer coverage, standardized service models, and established nucleic acid development infrastructure. The market remains characterized by a limited supplier base, highly customized projects, and revenues concentrated in the development stage.
Future competition will shift from basic circularization capability toward high purity, scarless products, long-sequence compatibility, low immunogenicity, and reproducible scale-up. Conventional PIE methods have a relatively established application base but may face challenges involving junction scars, sequence restrictions, and by-product control. Modified scarless PIE and ligase-based approaches offer greater sequence flexibility but impose additional requirements on terminal structure, splint design, enzyme cost, and downstream purification. As customer programs enter clinical development, residual linear RNA, double-stranded RNA, truncated transcripts, free intron fragments, and residual DNA will become increasingly important quality attributes. Suppliers with proprietary analytical methods and biological potency testing capabilities will gain a stronger competitive position.
Market growth is being driven by expanding development activity in circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo cell therapies, and gene-editing research. Compared with building internal in vitro transcription and circularization platforms, outsourcing gives developers access to validated templates, circularization elements, purification processes, and analytical systems, reducing development risk and shortening timelines to animal studies and regulatory submissions. As programs move from discovery to preclinical and clinical stages, additional testing for circularization efficiency, purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency expands the service scope and contract value. Providers offering integrated template production, circRNA drug substance, LNP formulation, and quality studies will be better positioned to secure long-term projects.
The main barriers are the lack of harmonized quality and regulatory standards and differences in how suppliers measure circularization efficiency, purity, integrity, and expression activity. A high apparent circularization rate does not necessarily indicate high functional purity, because mis-ligated products, uncircularized precursors, double-stranded RNA, and truncated transcripts may affect expression and immune responses. Long-sequence circularization efficiency, purification recovery, and batch consistency remain technical challenges. Clinical-grade production also involves significant costs related to high-grade raw materials, quality validation, facility maintenance, and regulatory documentation. Because the number of clinical-stage exogenous circRNA programs remains limited, GMP capacity utilization and order continuity also constrain the stability of supplier profitability.
LPI (LP Information)' newest research report, the ?Exogenous Circular RNA Synthesis Service Industry Forecast? looks at past sales and reviews total world Exogenous Circular RNA Synthesis Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Exogenous Circular RNA Synthesis Service sales for 2026 through 2032. With Exogenous Circular RNA Synthesis Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exogenous Circular RNA Synthesis Service industry.
This Insight Report provides a comprehensive analysis of the global Exogenous Circular RNA Synthesis Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exogenous Circular RNA Synthesis Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Exogenous Circular RNA Synthesis Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exogenous Circular RNA Synthesis Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exogenous Circular RNA Synthesis Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Exogenous Circular RNA Synthesis Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Custom Synthesis
- Process Development
- Analytical and QC Services
- Other
- PIE Circularization
- Enzymatic Ligation
- Other
- Naked circRNA
- circRNA-LNP
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GenScript Biotech Corporation
- VectorBuilder
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- Creative Biolabs
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exogenous Circular RNA Synthesis Service Market Size (2021-2032)
2.1.2 Exogenous Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Exogenous Circular RNA Synthesis Service by Country/Region (2021, 2025 & 2032)
2.2 Exogenous Circular RNA Synthesis Service Segment by Type
2.2.1 Custom Synthesis
2.2.2 Process Development
2.2.3 Analytical and QC Services
2.2.4 Other
2.2.5 Exogenous Circular RNA Synthesis Service Market Size by Type
2.2.5.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
2.3 Exogenous Circular RNA Synthesis Service Segment by Circularization Method
2.3.1 PIE Circularization
2.3.2 Enzymatic Ligation
2.3.3 Other
2.3.4 Exogenous Circular RNA Synthesis Service Market Size by Circularization Method
2.3.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
2.4 Exogenous Circular RNA Synthesis Service Segment by Product Format
2.4.1 Naked circRNA
2.4.2 circRNA-LNP
2.4.3 Other
2.4.4 Exogenous Circular RNA Synthesis Service Market Size by Product Format
2.4.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032)
2.4.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
2.5 Exogenous Circular RNA Synthesis Service Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 CRO and CDMO Companies
2.5.3 Other
2.5.4 Exogenous Circular RNA Synthesis Service Market Size by Application
2.5.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
3 EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE MARKET SIZE BY PLAYER
3.1 Exogenous Circular RNA Synthesis Service Market Size Market Share by Player
3.1.1 Global Exogenous Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.1.2 Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
3.2 Global Exogenous Circular RNA Synthesis Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE BY REGION
4.1 Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026)
4.2 Global Exogenous Circular RNA Synthesis Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.4 APAC Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.5 Europe Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026)
5.2 Americas Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3 Americas Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026)
6.2 APAC Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
6.3 APAC Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026)
7.2 Europe Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
7.3 Europe Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exogenous Circular RNA Synthesis Service by Region (2021-2026)
8.2 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE MARKET FORECAST
10.1 Global Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.1 Global Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.2 Americas Exogenous Circular RNA Synthesis Service Forecast
10.1.3 APAC Exogenous Circular RNA Synthesis Service Forecast
10.1.4 Europe Exogenous Circular RNA Synthesis Service Forecast
10.1.5 Middle East & Africa Exogenous Circular RNA Synthesis Service Forecast
10.2 Americas Exogenous Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.2.1 United States Market Exogenous Circular RNA Synthesis Service Forecast
10.2.2 Canada Market Exogenous Circular RNA Synthesis Service Forecast
10.2.3 Mexico Market Exogenous Circular RNA Synthesis Service Forecast
10.2.4 Brazil Market Exogenous Circular RNA Synthesis Service Forecast
10.3 APAC Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.3.1 China Exogenous Circular RNA Synthesis Service Market Forecast
10.3.2 Japan Market Exogenous Circular RNA Synthesis Service Forecast
10.3.3 Korea Market Exogenous Circular RNA Synthesis Service Forecast
10.3.4 Southeast Asia Market Exogenous Circular RNA Synthesis Service Forecast
10.3.5 India Market Exogenous Circular RNA Synthesis Service Forecast
10.3.6 Australia Market Exogenous Circular RNA Synthesis Service Forecast
10.4 Europe Exogenous Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.4.1 Germany Market Exogenous Circular RNA Synthesis Service Forecast
10.4.2 France Market Exogenous Circular RNA Synthesis Service Forecast
10.4.3 UK Market Exogenous Circular RNA Synthesis Service Forecast
10.4.4 Italy Market Exogenous Circular RNA Synthesis Service Forecast
10.4.5 Russia Market Exogenous Circular RNA Synthesis Service Forecast
10.5 Middle East & Africa Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Exogenous Circular RNA Synthesis Service Forecast
10.5.2 South Africa Market Exogenous Circular RNA Synthesis Service Forecast
10.5.3 Israel Market Exogenous Circular RNA Synthesis Service Forecast
10.5.4 Turkey Market Exogenous Circular RNA Synthesis Service Forecast
10.6 Global Exogenous Circular RNA Synthesis Service Forecast by Type (2027-2032)
10.7 Global Exogenous Circular RNA Synthesis Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Exogenous Circular RNA Synthesis Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Information
11.1.2 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product Offered
11.1.3 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GenScript Biotech Corporation Main Business Overview
11.1.5 GenScript Biotech Corporation Latest Developments
11.2 VectorBuilder
11.2.1 VectorBuilder Company Information
11.2.2 VectorBuilder Exogenous Circular RNA Synthesis Service Product Offered
11.2.3 VectorBuilder Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 VectorBuilder Main Business Overview
11.2.5 VectorBuilder Latest Developments
11.3 Guangzhou Geneseed Biotech
11.3.1 Guangzhou Geneseed Biotech Company Information
11.3.2 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product Offered
11.3.3 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guangzhou Geneseed Biotech Main Business Overview
11.3.5 Guangzhou Geneseed Biotech Latest Developments
11.4 uBriGene Biosciences
11.4.1 uBriGene Biosciences Company Information
11.4.2 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product Offered
11.4.3 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 uBriGene Biosciences Main Business Overview
11.4.5 uBriGene Biosciences Latest Developments
11.5 Yaohai Bio-Pharma
11.5.1 Yaohai Bio-Pharma Company Information
11.5.2 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product Offered
11.5.3 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Yaohai Bio-Pharma Main Business Overview
11.5.5 Yaohai Bio-Pharma Latest Developments
11.6 Creative Biogene
11.6.1 Creative Biogene Company Information
11.6.2 Creative Biogene Exogenous Circular RNA Synthesis Service Product Offered
11.6.3 Creative Biogene Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biogene Main Business Overview
11.6.5 Creative Biogene Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Exogenous Circular RNA Synthesis Service Product Offered
11.7.3 Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exogenous Circular RNA Synthesis Service Market Size (2021-2032)
2.1.2 Exogenous Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Exogenous Circular RNA Synthesis Service by Country/Region (2021, 2025 & 2032)
2.2 Exogenous Circular RNA Synthesis Service Segment by Type
2.2.1 Custom Synthesis
2.2.2 Process Development
2.2.3 Analytical and QC Services
2.2.4 Other
2.2.5 Exogenous Circular RNA Synthesis Service Market Size by Type
2.2.5.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
2.3 Exogenous Circular RNA Synthesis Service Segment by Circularization Method
2.3.1 PIE Circularization
2.3.2 Enzymatic Ligation
2.3.3 Other
2.3.4 Exogenous Circular RNA Synthesis Service Market Size by Circularization Method
2.3.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032)
2.3.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
2.4 Exogenous Circular RNA Synthesis Service Segment by Product Format
2.4.1 Naked circRNA
2.4.2 circRNA-LNP
2.4.3 Other
2.4.4 Exogenous Circular RNA Synthesis Service Market Size by Product Format
2.4.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032)
2.4.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
2.5 Exogenous Circular RNA Synthesis Service Segment by Application
2.5.1 Pharmaceutical and Biotechnology Companies
2.5.2 CRO and CDMO Companies
2.5.3 Other
2.5.4 Exogenous Circular RNA Synthesis Service Market Size by Application
2.5.4.1 Exogenous Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
3 EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE MARKET SIZE BY PLAYER
3.1 Exogenous Circular RNA Synthesis Service Market Size Market Share by Player
3.1.1 Global Exogenous Circular RNA Synthesis Service Revenue by Player (2021-2026)
3.1.2 Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
3.2 Global Exogenous Circular RNA Synthesis Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE BY REGION
4.1 Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026)
4.2 Global Exogenous Circular RNA Synthesis Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.4 APAC Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.5 Europe Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026)
5.2 Americas Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
5.3 Americas Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026)
6.2 APAC Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
6.3 APAC Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026)
7.2 Europe Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
7.3 Europe Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exogenous Circular RNA Synthesis Service by Region (2021-2026)
8.2 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOGENOUS CIRCULAR RNA SYNTHESIS SERVICE MARKET FORECAST
10.1 Global Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.1 Global Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.1.2 Americas Exogenous Circular RNA Synthesis Service Forecast
10.1.3 APAC Exogenous Circular RNA Synthesis Service Forecast
10.1.4 Europe Exogenous Circular RNA Synthesis Service Forecast
10.1.5 Middle East & Africa Exogenous Circular RNA Synthesis Service Forecast
10.2 Americas Exogenous Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.2.1 United States Market Exogenous Circular RNA Synthesis Service Forecast
10.2.2 Canada Market Exogenous Circular RNA Synthesis Service Forecast
10.2.3 Mexico Market Exogenous Circular RNA Synthesis Service Forecast
10.2.4 Brazil Market Exogenous Circular RNA Synthesis Service Forecast
10.3 APAC Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.3.1 China Exogenous Circular RNA Synthesis Service Market Forecast
10.3.2 Japan Market Exogenous Circular RNA Synthesis Service Forecast
10.3.3 Korea Market Exogenous Circular RNA Synthesis Service Forecast
10.3.4 Southeast Asia Market Exogenous Circular RNA Synthesis Service Forecast
10.3.5 India Market Exogenous Circular RNA Synthesis Service Forecast
10.3.6 Australia Market Exogenous Circular RNA Synthesis Service Forecast
10.4 Europe Exogenous Circular RNA Synthesis Service Forecast by Country (2027-2032)
10.4.1 Germany Market Exogenous Circular RNA Synthesis Service Forecast
10.4.2 France Market Exogenous Circular RNA Synthesis Service Forecast
10.4.3 UK Market Exogenous Circular RNA Synthesis Service Forecast
10.4.4 Italy Market Exogenous Circular RNA Synthesis Service Forecast
10.4.5 Russia Market Exogenous Circular RNA Synthesis Service Forecast
10.5 Middle East & Africa Exogenous Circular RNA Synthesis Service Forecast by Region (2027-2032)
10.5.1 Egypt Market Exogenous Circular RNA Synthesis Service Forecast
10.5.2 South Africa Market Exogenous Circular RNA Synthesis Service Forecast
10.5.3 Israel Market Exogenous Circular RNA Synthesis Service Forecast
10.5.4 Turkey Market Exogenous Circular RNA Synthesis Service Forecast
10.6 Global Exogenous Circular RNA Synthesis Service Forecast by Type (2027-2032)
10.7 Global Exogenous Circular RNA Synthesis Service Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Exogenous Circular RNA Synthesis Service Forecast
11 KEY PLAYERS ANALYSIS
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Information
11.1.2 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product Offered
11.1.3 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GenScript Biotech Corporation Main Business Overview
11.1.5 GenScript Biotech Corporation Latest Developments
11.2 VectorBuilder
11.2.1 VectorBuilder Company Information
11.2.2 VectorBuilder Exogenous Circular RNA Synthesis Service Product Offered
11.2.3 VectorBuilder Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 VectorBuilder Main Business Overview
11.2.5 VectorBuilder Latest Developments
11.3 Guangzhou Geneseed Biotech
11.3.1 Guangzhou Geneseed Biotech Company Information
11.3.2 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product Offered
11.3.3 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Guangzhou Geneseed Biotech Main Business Overview
11.3.5 Guangzhou Geneseed Biotech Latest Developments
11.4 uBriGene Biosciences
11.4.1 uBriGene Biosciences Company Information
11.4.2 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product Offered
11.4.3 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 uBriGene Biosciences Main Business Overview
11.4.5 uBriGene Biosciences Latest Developments
11.5 Yaohai Bio-Pharma
11.5.1 Yaohai Bio-Pharma Company Information
11.5.2 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product Offered
11.5.3 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Yaohai Bio-Pharma Main Business Overview
11.5.5 Yaohai Bio-Pharma Latest Developments
11.6 Creative Biogene
11.6.1 Creative Biogene Company Information
11.6.2 Creative Biogene Exogenous Circular RNA Synthesis Service Product Offered
11.6.3 Creative Biogene Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Creative Biogene Main Business Overview
11.6.5 Creative Biogene Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Exogenous Circular RNA Synthesis Service Product Offered
11.7.3 Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Exogenous Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Exogenous Circular RNA Synthesis Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Custom Synthesis
Table 4. Major Players of Process Development
Table 5. Major Players of Analytical and QC Services
Table 6. Major Players of Other
Table 7. Exogenous Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 10. Major Players of PIE Circularization
Table 11. Major Players of Enzymatic Ligation
Table 12. Major Players of Other
Table 13. Exogenous Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Exogenous Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026) & ($ millions)
Table 15. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
Table 16. Major Players of Naked circRNA
Table 17. Major Players of circRNA-LNP
Table 18. Major Players of Other
Table 19. Exogenous Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Exogenous Circular RNA Synthesis Service Market Size by Product Format (2021-2026) & ($ millions)
Table 21. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
Table 22. Exogenous Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 25. Global Exogenous Circular RNA Synthesis Service Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
Table 27. Exogenous Circular RNA Synthesis Service Key Players Head office and Products Offered
Table 28. Exogenous Circular RNA Synthesis Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 33. Global Exogenous Circular RNA Synthesis Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 37. Americas Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 39. Americas Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 41. APAC Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 43. APAC Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 47. Europe Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Exogenous Circular RNA Synthesis Service
Table 53. Key Market Challenges & Risks of Exogenous Circular RNA Synthesis Service
Table 54. Key Industry Trends of Exogenous Circular RNA Synthesis Service
Table 55. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. GenScript Biotech Corporation Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 60. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product Offered
Table 61. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. GenScript Biotech Corporation Main Business
Table 63. GenScript Biotech Corporation Latest Developments
Table 64. VectorBuilder Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 65. VectorBuilder Exogenous Circular RNA Synthesis Service Product Offered
Table 66. VectorBuilder Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. VectorBuilder Main Business
Table 68. VectorBuilder Latest Developments
Table 69. Guangzhou Geneseed Biotech Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 70. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product Offered
Table 71. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Guangzhou Geneseed Biotech Main Business
Table 73. Guangzhou Geneseed Biotech Latest Developments
Table 74. uBriGene Biosciences Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 75. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product Offered
Table 76. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. uBriGene Biosciences Main Business
Table 78. uBriGene Biosciences Latest Developments
Table 79. Yaohai Bio-Pharma Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 80. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product Offered
Table 81. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Yaohai Bio-Pharma Main Business
Table 83. Yaohai Bio-Pharma Latest Developments
Table 84. Creative Biogene Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 85. Creative Biogene Exogenous Circular RNA Synthesis Service Product Offered
Table 86. Creative Biogene Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 90. Creative Biolabs Exogenous Circular RNA Synthesis Service Product Offered
Table 91. Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
Table 1. Exogenous Circular RNA Synthesis Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Exogenous Circular RNA Synthesis Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Custom Synthesis
Table 4. Major Players of Process Development
Table 5. Major Players of Analytical and QC Services
Table 6. Major Players of Other
Table 7. Exogenous Circular RNA Synthesis Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 10. Major Players of PIE Circularization
Table 11. Major Players of Enzymatic Ligation
Table 12. Major Players of Other
Table 13. Exogenous Circular RNA Synthesis Service Market Size CAGR by Circularization Method (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Exogenous Circular RNA Synthesis Service Market Size by Circularization Method (2021-2026) & ($ millions)
Table 15. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method (2021-2026)
Table 16. Major Players of Naked circRNA
Table 17. Major Players of circRNA-LNP
Table 18. Major Players of Other
Table 19. Exogenous Circular RNA Synthesis Service Market Size CAGR by Product Format (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Exogenous Circular RNA Synthesis Service Market Size by Product Format (2021-2026) & ($ millions)
Table 21. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format (2021-2026)
Table 22. Exogenous Circular RNA Synthesis Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 25. Global Exogenous Circular RNA Synthesis Service Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player (2021-2026)
Table 27. Exogenous Circular RNA Synthesis Service Key Players Head office and Products Offered
Table 28. Exogenous Circular RNA Synthesis Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 33. Global Exogenous Circular RNA Synthesis Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 37. Americas Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Table 39. Americas Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Table 41. APAC Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Table 43. APAC Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Country (2021-2026)
Table 47. Europe Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Exogenous Circular RNA Synthesis Service
Table 53. Key Market Challenges & Risks of Exogenous Circular RNA Synthesis Service
Table 54. Key Industry Trends of Exogenous Circular RNA Synthesis Service
Table 55. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Exogenous Circular RNA Synthesis Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. GenScript Biotech Corporation Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 60. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product Offered
Table 61. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. GenScript Biotech Corporation Main Business
Table 63. GenScript Biotech Corporation Latest Developments
Table 64. VectorBuilder Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 65. VectorBuilder Exogenous Circular RNA Synthesis Service Product Offered
Table 66. VectorBuilder Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. VectorBuilder Main Business
Table 68. VectorBuilder Latest Developments
Table 69. Guangzhou Geneseed Biotech Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 70. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product Offered
Table 71. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Guangzhou Geneseed Biotech Main Business
Table 73. Guangzhou Geneseed Biotech Latest Developments
Table 74. uBriGene Biosciences Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 75. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product Offered
Table 76. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. uBriGene Biosciences Main Business
Table 78. uBriGene Biosciences Latest Developments
Table 79. Yaohai Bio-Pharma Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 80. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product Offered
Table 81. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Yaohai Bio-Pharma Main Business
Table 83. Yaohai Bio-Pharma Latest Developments
Table 84. Creative Biogene Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 85. Creative Biogene Exogenous Circular RNA Synthesis Service Product Offered
Table 86. Creative Biogene Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Creative Biogene Main Business
Table 88. Creative Biogene Latest Developments
Table 89. Creative Biolabs Details, Company Type, Exogenous Circular RNA Synthesis Service Area Served and Its Competitors
Table 90. Creative Biolabs Exogenous Circular RNA Synthesis Service Product Offered
Table 91. Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Creative Biolabs Main Business
Table 93. Creative Biolabs Latest Developments
LIST OF FIGURES
Figure 1. Exogenous Circular RNA Synthesis Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exogenous Circular RNA Synthesis Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Exogenous Circular RNA Synthesis Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Exogenous Circular RNA Synthesis Service Sales Market Share by Country/Region (2025)
Figure 8. Exogenous Circular RNA Synthesis Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 10. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 11. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 12. Exogenous Circular RNA Synthesis Service in Pharmaceutical and Biotechnology Companies
Figure 13. Global Exogenous Circular RNA Synthesis Service Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Exogenous Circular RNA Synthesis Service in CRO and CDMO Companies
Figure 15. Global Exogenous Circular RNA Synthesis Service Market: CRO and CDMO Companies (2021-2026) & ($ millions)
Figure 16. Exogenous Circular RNA Synthesis Service in Other
Figure 17. Global Exogenous Circular RNA Synthesis Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 19. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player in 2025
Figure 20. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Exogenous Circular RNA Synthesis Service Value Market Share by Country in 2025
Figure 26. United States Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Region in 2025
Figure 31. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 33. China Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Country in 2025
Figure 40. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 59. United States Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 63. China Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 67. India Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 70. France Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 71. UK Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 78. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 1. Exogenous Circular RNA Synthesis Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exogenous Circular RNA Synthesis Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Exogenous Circular RNA Synthesis Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Exogenous Circular RNA Synthesis Service Sales Market Share by Country/Region (2025)
Figure 8. Exogenous Circular RNA Synthesis Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Type in 2025
Figure 10. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Circularization Method in 2025
Figure 11. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Product Format in 2025
Figure 12. Exogenous Circular RNA Synthesis Service in Pharmaceutical and Biotechnology Companies
Figure 13. Global Exogenous Circular RNA Synthesis Service Market: Pharmaceutical and Biotechnology Companies (2021-2026) & ($ millions)
Figure 14. Exogenous Circular RNA Synthesis Service in CRO and CDMO Companies
Figure 15. Global Exogenous Circular RNA Synthesis Service Market: CRO and CDMO Companies (2021-2026) & ($ millions)
Figure 16. Exogenous Circular RNA Synthesis Service in Other
Figure 17. Global Exogenous Circular RNA Synthesis Service Market: Other (2021-2026) & ($ millions)
Figure 18. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Application in 2025
Figure 19. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Player in 2025
Figure 20. Global Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 21. Americas Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 22. APAC Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 23. Europe Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size 2021-2026 ($ millions)
Figure 25. Americas Exogenous Circular RNA Synthesis Service Value Market Share by Country in 2025
Figure 26. United States Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Region in 2025
Figure 31. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 32. APAC Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 33. China Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 37. India Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Country in 2025
Figure 40. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 41. Europe Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 42. Germany Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 43. France Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Exogenous Circular RNA Synthesis Service Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 56. APAC Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 57. Europe Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 59. United States Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 60. Canada Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 61. Mexico Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 62. Brazil Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 63. China Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 64. Japan Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 65. Korea Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 67. India Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 68. Australia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 69. Germany Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 70. France Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 71. UK Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 72. Italy Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 73. Russia Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 74. Egypt Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 75. South Africa Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 76. Israel Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 77. Turkey Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
Figure 78. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Exogenous Circular RNA Synthesis Service Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Exogenous Circular RNA Synthesis Service Market Size 2027-2032 ($ millions)
